作者:
Bellone, Matteo [1]
;
Brevi, Arianna [2]
;
Bruzzi, Stefania [3]
;
Consonni, Michela [4]
;
De Santis, Francesca [5]
;
Di Lullo, Giulia [6]
;
Majorini, Maria Teresa [7]
;
Pasto, Anna [8]
;
Amadori, Alberto [9]
;
Bregni, Marco [10]
;
Di Nicola, Massimo [11]
;
Calabro, Luana [12]
;
Ferrucci, Pier Francesco ;
Proietti, Enrico ;
Colombo, Mario Paolo ;
Russo, Vincenzo
作者单位:
Fdn IRCCS Ist Nazl Tumori, Unit Immunotherapy & Anticancer Innovat Therapeut, Milan, Italy
[1]
Fdn IRCCS Ist Nazl Tumori, Unit Mol Immunol, Milan, Italy
[2]
IRCCS Osped San Raffaele, Unit Cellular Immunol, Milan, Italy
[3]
Univ Hosp Siena, Med Oncol & Immunotherapy, Siena, Italy
[4]
Univ Padua, Padua, Italy
[5]
Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy
[6]
Osped Circolo Busto Arsizio, ASST Valle Olona, Oncol Unit, Busto Arsizio, Italy
[7]
IRCCS Osped San Raffaele, Unit Tumor Immunol, Milan, Italy
[8]
Ist Super Sanita, Dept Haematol Oncol & Mol Med, Rome, Italy
[9]
IRCCS Osped San Raffaele, Unit Immunobiotherapy Melanoma & Solid Tumors, Milan, Italy
[10]
European Inst Oncol IRCCS, Milan, Italy
[11]
IRCCS Osped San Raffaele, Unit Expt Immunol, Milan, Italy
[12]
发布时间
2021-02-08